Skip to main content

Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer.

Moatamed NA, Nanjangud G, Pucci R, Lowe A, Shintaku IP, Shapourifar-Tehrani S, Rao N, Lu DY, Apple SK

Publication: Am J Clin Pathol (2011) • Vol 136 • Page 754-61PMID: 22031314View on PubMed

Purpose

The purpose of this paper was to determine the effects of fixation parameters on the evaluation of human epidermal growth factor 2 (HER2) status of breast cancer specimens.

Conclusion

Delaying fixation by 4 days did not effect determination of HER2 status by immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH). The most consistent IHC results were obtained from specimens fixed with Pen-FIX for 1-168 h, or 10% neutral buffered formalin (NBF) for more than 72 h. The most consistent FISH results were obtained from specimens fixed in 10% NBF for 1-168 h, or Pen-Fix, Sakura molecular fixative (SMF), or zinc formalin for 7 h or less.

Studies (2)

Purpose

The purpose of this study was to determine the effects of fixation parameters on the evaluation of HER2 status in breast cancer specimens by IHC. A portion of a single grade 3 invasive ductal carcinoma was fixed in 10% NBF for 12 h, and the remainder was stored for 4 days at 4 degrees C prior to fixation for 0-168 h in each of the tested fixatives. IHC staining was performed using the HercepTest and was scored using the American society of clinical oncologists (ASCO)/ College of American pathologists (CAP) guidelines.

Summary of Findings

In the specimen that was immediately fixed in 10% NBF for 12 h the IHC score was 3+ and. The authors report that the 4 days of cold ischemia time at 4 degrees C prior to fixation did not impact IHC results or quality of morphology. The most consistent results were obtained when the specimen was fixed with Pen-FIX resulting in scores of 3+ for all fixation times (1-168 h). When the specimens were fixed in 10% NBF, fixation for 1 h yielded a HER2 score of 1+, and fixation for 2-48 h led to variable scores of 2+ or 3+, but fixation for 72 h or longer resulted in consistent HER2 scores of 3+. Fixation in 15% NBF, SMF, and zinc formalin generally led to a HER2 score of 3+, but specimens fixed in 15% NBF for 10-24 h, SMF for 1 or 12 h, or zinc formalin for 1, 24 or 168 h scored 2+. Fixation in Bouin's fixative for 1 h led to a HER2 score of 1+, and longer fixation times led to scores of 2+ or 3+ with equal frequency and no trends were observed.

  • Biospecimens

    TissueBreast
  • Preservation Types

    FormalinNone (Fresh)Other Preservative
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    MorphologyH-and-E microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionCold ischemia time
    4 days
    < 1 h
    Biospecimen PreservationConcentration of fixative
    10% NBF
    15% NBF
    Biospecimen PreservationTime in fixative
    0 h
    1 h
    10 h
    11 h
    12 h
    168 h
    2 h
    24 h
    3 h
    4 h
    48 h
    5 h
    6 h
    7 h
    72 h
    8 h
    9 h
    Biospecimen PreservationType of fixation/preservation
    Bouin's fixative
    Formalin (buffered)
    None (fresh)
    Pen-fix
    Sakura molecular fixative
    Zinc formalin
    Immunohistochemistry SpecificTargeted peptide/protein
    HER2